Bahrain vs Switzerland: Cause of death, by non-communicable diseases, ages 5-14, male
Bahrain
54.0%
in 2021
Switzerland
54.5%
in 2021
Bahrain rank
42nd
Switzerland rank
40th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Bahrain
- Switzerland
How they compare
Switzerland currently reports 54.5% against 54.0% in Bahrain, a difference of 0.5%.
Across all 6 years both countries report, Switzerland has been ahead every year.
Bahrain ranks 42nd and Switzerland ranks 40th of 185 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.9% | 50.2% | 6.3% | Switzerland |
| 2010s | 52.9% | 59.8% | 6.9% | Switzerland |
| 2020s | 54.9% | 61.1% | 6.1% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Bahrain or Switzerland?
- Switzerland, at 54.5% against 54.0% in Bahrain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Bahrain and Switzerland?
- 0.5%, with Switzerland ahead.
- How many years of comparable data are there for Bahrain and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Switzerland rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Bahrain ranks 42nd and Switzerland ranks 40th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.